Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Tempo Intimedia Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp254 (kapitalisasi pasar 172,82 M, volume 24 jam 592,2 rb), sedangkan Tempo Intimedia Tbk. diperdagangkan di Rp106 (kapitalisasi pasar 113,24 M, volume 24 jam 4,58 jt). Perbedaan utamanya: Brigit Biofarmaka Teknologi Tbk. lebih besar dari sisi kapitalisasi pasar, dan Tempo Intimedia Tbk. lebih aktif diperdagangkan (4,58 jt vs 592,2 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | TMPO | |
|---|---|---|
Kapitalisasi Pasar | 172,82 M | 113,24 M |
Volume | 592,2 rb | 4,58 jt |
Lot | 5,92 rb | 45,79 rb |
Perputaran | 147,05 jt | 486,79 jt |
Harga Rata-rata | 248,31 | 106,32 |
Nilai Transaksi | 147,05 jt | 486,79 jt |
Harga Ekuilibrium Indikatif | 254 | 106 |
Volume Ekuilibrium Indikatif | 10 | 198 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT Tempo Inti Media Tbk (the Company) was established under its origin name of PT Arsa Raya Perdana on August 27, 1996 , based on deed No.77 of notary Sulaimansjah, SH. The Company’s articles of association has been amended from time to time, the latest of which was drawn up in notarial deed No.49 dated Sept 29, 2000 of Fathiah Helmi, S.H., relating to, among others, the change of company's name, the increase in authorized and issued capital of the Company in connection with the first offering, and stock split.
Selengkapnya di halaman TMPO →